SHENZHEN KANGTAI B revenue breakdown overview

SHENZHEN KANGTAI B revenue for the last year amounted to 3.48 B CNY, the most of which — 3.44 B CNY — came from its highest performing source at the moment, Non-immunization Program Vaccines, the year earlier bringing 2.90 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHENZHEN KANGTAI B 3.48 B CNY, and the year before that — 3.16 B CNY.